Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety...

by Stephen Silberstein, Merle Diamond, Nada A. Hindiyeh, David M. Biondi, Roger Cady, Joe Hirman, Brent Allan, Susan Pederson, Barbara Schaeffler, Jeff Smith
Published 2020-10-01

The status and high risk factors of severe psychological distress in migraine patients during nCOV-2019 outbreak in Southwest China: a cross-sectional study

by Mengmeng Ma, Jinghuan Fang, Changling Li, Jiajia Bao, Yang Zhang, Ning Chen, Jian Guo, Li He
Published 2020-08-01

Favourable prognosis of trigeminal neuralgia when enrolled in a multidisciplinary management program - a two-year prospective real-life study

by Tone Bruvik Heinskou, Stine Maarbjerg, Frauke Wolfram, Per Rochat, Jannick Brennum, Jes Olesen, Lars Bendtsen
Published 2019-03-01

Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence

by T. J. Steiner, H. Göbel, R. Jensen, C. Lampl, K. Paemeleire, M. Linde, M. Braschinsky, D. Mitsikostas, R. Gil-Gouveia, Z. Katsarava, on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache
Published 2019-03-01

ROS/TRPA1/CGRP signaling mediates cortical spreading depression

by Liwen Jiang, Dongqing Ma, Blair D. Grubb, Minyan Wang
Published 2019-03-01

Migraine-provoking substances evoke periorbital allodynia in mice

by Francesco De Logu, Lorenzo Landini, Malvin N. Janal, Simone Li Puma, Francesco De Cesaris, Pierangelo Geppetti, Romina Nassini
Published 2019-02-01

How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice

by Cindy Tiseo, Raffaele Ornello, Francesca Pistoia, Simona Sacco
Published 2019-05-01

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers...

by Rosaria Greco, Roberto De Icco, Chiara Demartini, Anna Maria Zanaboni, Elena Tumelero, Grazia Sances, Marta Allena, Cristina Tassorelli
Published 2020-10-01

Modulation of mechanosensory vibrissal responses in the trigeminocervical complex by stimulation of the greater occipital nerve in a rat model of trigeminal neuropathic pain

by Nuria García-Magro, Pilar Negredo, Yasmina B. Martin, Ángel Nuñez, Carlos Avendaño
Published 2020-08-01

A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB

by Giuseppe Tringali, Catello Vollono, Paolo Calabresi, Pierluigi Navarra
Published 2020-10-01

Lasmiditan mechanism of action – review of a selective 5-HT1F agonist

by David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, Michael H. Ossipov, Ann M. Hake, Andrew M. Blumenfeld
Published 2020-06-01

A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years

by Carlo Piccinni, Sabina Cevoli, Giulia Ronconi, Letizia Dondi, Silvia Calabria, Antonella Pedrini, Immacolata Esposito, Valentina Favoni, Giulia Pierangeli, Pietro Cortelli, Nello Martini
Published 2019-06-01

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

by Willem Sebastiaan van Hoogstraten, Antoinette MaassenVanDenBrink
Published 2019-05-01

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

by Silvia Benemei, Alejandro Labastida-Ramírez, Ekaterina Abramova, Nicoletta Brunelli, Edoardo Caronna, Paola Diana, Roman Gapeshin, Maxi Dana Hofacker, Ilaria Maestrini, Enrique Martínez Pías, Petr Mikulenka, Olga Tikhonova, Paolo Martelletti, Antoinette MaassenVanDenBrink, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Published 2020-07-01

Patients with chronic migraine without history of medication overuse are characterized by a peculiar white matter fiber bundle profile

by Gianluca Coppola, Antonio Di Renzo, Emanuele Tinelli, Barbara Petolicchio, Cherubino Di Lorenzo, Vincenzo Parisi, Mariano Serrao, Valentina Calistri, Stefano Tardioli, Gaia Cartocci, Francesca Caramia, Vittorio Di Piero, Francesco Pierelli
Published 2020-07-01

Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study

by Javier Trigo, David García-Azorín, Álvaro Planchuelo-Gómez, Enrique Martínez-Pías, Blanca Talavera, Isabel Hernández-Pérez, Gonzalo Valle-Peñacoba, Paula Simón-Campo, Mercedes de Lera, Alba Chavarría-Miranda, Cristina López-Sanz, María Gutiérrez-Sánchez, Elena Martínez-Velasco, María Pedraza, Álvaro Sierra, Beatriz Gómez-Vicente, Juan Francisco Arenillas, Ángel L. Guerrero
Published 2020-07-01

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

by Antonio Russo, Marcello Silvestro, Fabrizio Scotto di Clemente, Francesca Trojsi, Alvino Bisecco, Simona Bonavita, Alessandro Tessitore, Gioacchino Tedeschi
Published 2020-06-01

The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study

by Diana Genc, Nerija Vaičienė-Magistris, Apolinaras Zaborskis, Tayyar Şaşmaz, Aylin Yeniocak Tunç, Derya Uluduz, Timothy J. Steiner
Published 2020-06-01

Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis

by Tatjana Roessler, Juergen Zschocke, Anne Roehrig, Michael Friedrichs, Heiko Friedel, Zaza Katsarava
Published 2020-07-01

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA

by Marta Torres-Ferrus, Victor José Gallardo, Alicia Alpuente, Patricia Pozo-Rosich
Published 2020-07-01